NM_001278293.3:c.255-49A>G
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001278293.3(ARL6):c.255-49A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0122 in 1,408,448 control chromosomes in the GnomAD database, including 136 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0092 ( 13 hom., cov: 32)
Exomes 𝑓: 0.013 ( 123 hom. )
Consequence
ARL6
NM_001278293.3 intron
NM_001278293.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0530
Publications
0 publications found
Genes affected
ARL6 (HGNC:13210): (ADP ribosylation factor like GTPase 6) The protein encoded by this gene belongs to the ARF-like (ADP ribosylation factor-like) sub-family of the ARF family of GTP-binding proteins which are involved in regulation of intracellular traffic. Mutations in this gene are associated with Bardet-Biedl syndrome (BBS). A vision-specific transcript, encoding long isoform BBS3L, has been described (PMID: 20333246). [provided by RefSeq, Apr 2016]
ARL6 Gene-Disease associations (from GenCC):
- Bardet-Biedl syndrome 3Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp, G2P
- retinitis pigmentosa 55Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- retinitis pigmentosaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Bardet-Biedl syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 3-97784906-A-G is Benign according to our data. Variant chr3-97784906-A-G is described in ClinVar as Likely_benign. ClinVar VariationId is 262015.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00922 (1402/152120) while in subpopulation NFE AF = 0.0152 (1032/67864). AF 95% confidence interval is 0.0144. There are 13 homozygotes in GnomAd4. There are 663 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 13 AR,AD gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00922 AC: 1402AN: 152002Hom.: 13 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
1402
AN:
152002
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00887 AC: 2011AN: 226724 AF XY: 0.00871 show subpopulations
GnomAD2 exomes
AF:
AC:
2011
AN:
226724
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0125 AC: 15766AN: 1256328Hom.: 123 Cov.: 17 AF XY: 0.0120 AC XY: 7620AN XY: 634438 show subpopulations
GnomAD4 exome
AF:
AC:
15766
AN:
1256328
Hom.:
Cov.:
17
AF XY:
AC XY:
7620
AN XY:
634438
show subpopulations
African (AFR)
AF:
AC:
69
AN:
28722
American (AMR)
AF:
AC:
395
AN:
43522
Ashkenazi Jewish (ASJ)
AF:
AC:
103
AN:
24686
East Asian (EAS)
AF:
AC:
0
AN:
37662
South Asian (SAS)
AF:
AC:
22
AN:
80702
European-Finnish (FIN)
AF:
AC:
171
AN:
51126
Middle Eastern (MID)
AF:
AC:
25
AN:
5326
European-Non Finnish (NFE)
AF:
AC:
14356
AN:
931452
Other (OTH)
AF:
AC:
625
AN:
53130
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
771
1541
2312
3082
3853
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
500
1000
1500
2000
2500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00922 AC: 1402AN: 152120Hom.: 13 Cov.: 32 AF XY: 0.00892 AC XY: 663AN XY: 74362 show subpopulations
GnomAD4 genome
AF:
AC:
1402
AN:
152120
Hom.:
Cov.:
32
AF XY:
AC XY:
663
AN XY:
74362
show subpopulations
African (AFR)
AF:
AC:
103
AN:
41570
American (AMR)
AF:
AC:
205
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
AC:
17
AN:
3470
East Asian (EAS)
AF:
AC:
1
AN:
5194
South Asian (SAS)
AF:
AC:
1
AN:
4826
European-Finnish (FIN)
AF:
AC:
22
AN:
10602
Middle Eastern (MID)
AF:
AC:
1
AN:
292
European-Non Finnish (NFE)
AF:
AC:
1032
AN:
67864
Other (OTH)
AF:
AC:
19
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
71
143
214
286
357
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3
AN:
3468
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.